Rein Therapeutics, Inc. (NASDAQ:RNTX) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| William McKee Other companies: Assertio Holdings, Inc. (Director · Since at least May 19, 2020); C4 Therapeutics, Inc. (Chief Financial Officer · Oct 1, 2020 – Oct 6, 2020 · Past); Depomed Inc (Director · Mar 28, 2017 – May 8, 2018 · Past); Dare Bioscience, Inc. (Director · Apr 10, 2014 – Jan 3, 2017 · Past); Auxilium Pharmaceuticals Inc (Director · Mar 18, 2009 – Jan 29, 2015 · Past); Barr Pharmaceuticals Inc (EVP, CFO · Jan 3, 2006 – Dec 23, 2008 · Past) | Director · Jun 19, 2019 – Jun 15, 2022 · Past |
| Jeffrey Bailey Other companies: Aurinia Pharmaceuticals Inc (Board Director · Since at least Aug 18, 2023); BioDelivery Sciences International Inc (Chief Executive Officer, Director · Mar 9, 2020 – Mar 22, 2022 · Past); Lantheus Holdings, Inc. (CEO and President, Director · Jun 24, 2015 – Aug 31, 2015 · Past); Landauer Inc (Director · Apr 17, 2015 – Oct 19, 2017 · Past); King Pharmaceuticals Inc (Chief Commercial Officer · Aug 30, 2010 – Mar 1, 2011 · Past) | Director · Mar 15, 2018 – Jun 17, 2022 · Past |
| Jodie Morrison Other companies: Verve Therapeutics Inc (Director · Since at least Jun 26, 2024); Q32 Bio Inc. (Chief Executive Officer · Since at least Mar 25, 2024); Akebia Therapeutics, Inc. (Director · Dec 12, 2018 – Jun 6, 2019 · Past); Keryx Biopharmaceuticals Inc (Interim CEO, Director · Jun 21, 2016 – Dec 12, 2018 · Past); Eledon Pharmaceuticals, Inc. (Director · Sep 16, 2014 – Jun 30, 2017 · Past) | Director · Jun 28, 2017 – Jun 15, 2022 · Past |
| William C. Fairey Other companies: Ascendis Pharma A/S (Director · Since at least Mar 18, 2026); KalVista Pharmaceuticals, Inc. (Director · Since at least Apr 18, 2024); Mirum Pharmaceuticals, Inc. (Director · Since at least Aug 19, 2021); MyoKardia Inc (EVP, Chief Commercial Officer · Jan 28, 2019 – Nov 17, 2020 · Past); ChemoCentryx Inc. (Chief Operating Officer · Jan 3, 2018 – Jan 3, 2018 · Past) | Director · Since at least Oct 31, 2023 |
| Alan A Musso Other companies: Research Alliance Corporation IV (Director · Since at least Jul 10, 2026); Fulcrum Therapeutics, Inc. (Chief Financial Officer · Since at least Aug 7, 2023); Bellicum Pharmaceuticals Inc (CFO and Treasurer · Dec 17, 2014 – Jul 2, 2018 · Past); Gyre Therapeutics, Inc. (SVP, Fin+Admin, CFO & Treas · Apr 11, 2006 – Oct 17, 2014 · Past) | Director · Since at least Oct 31, 2023 |
| Muneer A Satter Other companies: Annexon, Inc. (Director · Since at least Jul 23, 2020); Whitehawk Therapeutics, Inc. (Director · Mar 15, 2017 – Jun 18, 2019 · Past); Immunic, Inc. (Director · Apr 16, 2014 – Sep 13, 2018 · Past); Akebia Therapeutics, Inc. (Director · Mar 19, 2014 – Jun 14, 2018 · Past) | See Remarks, Director · Jun 8, 2020 – Jan 8, 2021 · Past |
| Armen Shanafelt Other companies: Surface Oncology Inc (Director · Apr 18, 2018 – Jun 8, 2022 · Past); Protagonist Therapeutics, Inc. (Director · Aug 10, 2016 – May 29, 2018 · Past); Spyre Therapeutics, Inc. (Director · Apr 6, 2016 – Jun 7, 2022 · Past) | Director · Jun 28, 2017 – Jun 21, 2018 · Past |
| John H McArthur Other companies: Cabot Corporation (Director · Sep 29, 2006 – Jan 12, 2007 · Past); HCA Healthcare, Inc. (Director · May 25, 2006 – May 25, 2006 · Past); The AES Corporation (Director · May 11, 2006 – Oct 12, 2007 · Past) | Director · Jun 28, 2017 – Jun 19, 2019 · Past |
| Josef H Von Rickenbach Other companies: NextGen Acquisition Corp. II (Director · Mar 22, 2021 – Mar 22, 2021 · Past); Xos, Inc. (Director · Oct 6, 2020 – Oct 6, 2020 · Past); PAREXEL International Corp (Chairman & CEO, Director · Sep 30, 2008 – Sep 29, 2017 · Past) | Director · Since at least Jun 19, 2019 |
| Timothy M Cunningham Other companies: Neuphoria Therapeutics Inc. (Chief Financial Officer · Jul 1, 2024 – Jul 1, 2024 · Past); Alaunos Therapeutics, Inc. (interim CFO · Feb 17, 2021 – Feb 17, 2021 · Past); Organogenesis Holdings Inc. (Chief Financial Officer · Dec 10, 2018 – Apr 22, 2020 · Past) | See Remarks · May 16, 2024 – May 16, 2024 · Past |
| Brian M Gallagher Jr Other companies: eFFECTOR Therapeutics Inc (Director · Aug 25, 2021 – Jun 13, 2024 · Past); Translate Bio Inc (Director · Jun 27, 2018 – Jul 2, 2018 · Past) | Director · Jun 28, 2017 – Jul 25, 2017 · Past |
| Susan L Drexler Other companies: Kiora Pharmaceuticals, Inc. (Interim CFO · Apr 21, 2022 – Apr 21, 2022 · Past); Harmony Biosciences Holdings, Inc. (Chief Financial Officer · Aug 18, 2020 – Aug 18, 2020 · Past) | See Remarks · Jun 15, 2022 – Jun 15, 2022 · Past |
| Vojo Vukovic Other companies: Delcath Systems, Inc. (CHIEF MEDICAL OFFICER · Since at least Jun 19, 2023); Madrigal Pharmaceuticals, Inc. (SVP, Chief Medical Officer · Jul 13, 2009 – Oct 2, 2015 · Past) | Chief Medical Officer · Nov 5, 2018 – Mar 30, 2022 · Past |
| Charles Garner Other companies: Recro Pharma Inc (CFO and Chief Business Officer · Mar 6, 2014 – Jun 5, 2015 · Past) | Senior Vice President, Finance · Mar 25, 2024 – Mar 25, 2024 · Past |
| James Brian Windsor Other companies: TFF Pharmaceuticals Inc (Chief Science Officer, Director · Oct 24, 2019 – Dec 7, 2020 · Past) | See Remarks, Director · Since at least Oct 31, 2023 |
| John P Phd Longenecker Other companies: Pacira BioSciences, Inc. (Director · Feb 2, 2011 – Mar 3, 2022 · Past) | President and CEO · May 15, 2018 – Aug 10, 2018 · Past |
| Joseph A Yanchik III Other companies: Eledon Pharmaceuticals, Inc. (Director · Sep 16, 2014 – Jun 15, 2016 · Past) | See Remarks, Director · Jun 28, 2017 – Jul 25, 2017 · Past |
| Kathryn Gregory Other companies: Longevity Health Holdings, Inc. (Director · Jul 14, 2023 – Oct 11, 2024 · Past) | SVP, Chief Business Officer · Feb 25, 2019 – Jan 31, 2020 · Past |
| Rick Wanstall Other companies: Oncorus Inc (CFO and Treasurer · May 10, 2022 – May 25, 2022 · Past) | See Remarks · Mar 27, 2019 – Mar 30, 2022 · Past |
| Tim Cunningham Other companies: Neuphoria Therapeutics Inc. (Fractional CFO · Since at least Nov 4, 2026) | Interim Chief Financial Officer · Since at least Nov 4, 2026 |
| Allen Annis | SVP, Research · Nov 3, 2018 – Mar 30, 2022 · Past |
| Brian Windsor | President and CEO · Since at least Nov 2, 2026 |
| Caleb Maxfield Winder | Director · Jun 28, 2017 – Jun 21, 2018 · Past |
| Cory Hogaboam | Chief Scientific Officer · Since at least Aug 4, 2026 |
| Donald Dougherty | SVP & Chief Financial Officer · Jun 28, 2017 – Apr 15, 2019 · Past |
| Kira Nelson | See Remarks · Jun 28, 2017 – Jul 25, 2017 · Past |
| Kristie Lauterbach | VP, Quality Assurance · Since at least Nov 5, 2026 |
| Manuel Aivado | Director · Since at least Jun 28, 2017 |
| Matt Karpen | VP, CMC · Since at least Nov 4, 2026 |
| Nolan Howard Sigal | Director · Apr 2, 2019 – Jun 15, 2022 · Past |
| Reinhard J Ambros | Director · Since at least Jun 28, 2017 |
| Ron Chen | VP, Finance and Corporate Controller · Since at least Nov 4, 2026 |
| Scott Kapnick | Director · Aug 14, 2018 – Aug 14, 2018 · Past |